BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Plavec TV, Kuchař M, Benko A, Lišková V, Černý J, Berlec A, Malý P. Engineered Lactococcus lactis Secreting IL-23 Receptor-Targeted REX Protein Blockers for Modulation of IL-23/Th17-Mediated Inflammation. Microorganisms 2019;7:E152. [PMID: 31137908 DOI: 10.3390/microorganisms7050152] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Mccoubrey LE, Elbadawi M, Basit AW. Current clinical translation of microbiome medicines. Trends in Pharmacological Sciences 2022. [DOI: 10.1016/j.tips.2022.02.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Plavec TV, Mitrović A, Perišić Nanut M, Štrukelj B, Kos J, Berlec A. Targeting of fluorescent Lactococcus lactis to colorectal cancer cells through surface display of tumour-antigen binding proteins. Microb Biotechnol 2021. [PMID: 34347360 DOI: 10.1111/1751-7915.13907] [Reference Citation Analysis]
3 Hartwig O, Shetab Boushehri MA, Shalaby KS, Loretz B, Lamprecht A, Lehr CM. Drug delivery to the inflamed intestinal mucosa - targeting technologies and human cell culture models for better therapies of IBD. Adv Drug Deliv Rev 2021;175:113828. [PMID: 34157320 DOI: 10.1016/j.addr.2021.113828] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
4 Plavec TV, Zahirović A, Zadravec P, Sabotič J, Berlec A. Lectin-Mediated Binding of Engineered Lactococcus lactis to Cancer Cells. Microorganisms 2021;9:223. [PMID: 33499141 DOI: 10.3390/microorganisms9020223] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Sasi M, Kumar S, Hasan M, S R A, Garcia-Gutierrez E, Kumari S, Prakash O, Nain L, Sachdev A, Dahuja A. Current trends in the development of soy-based foods containing probiotics and paving the path for soy-synbiotics. Crit Rev Food Sci Nutr 2022;:1-19. [PMID: 35611888 DOI: 10.1080/10408398.2022.2078272] [Reference Citation Analysis]
6 Pastor-Fernández G, Mariblanca IR, Navarro MN. Decoding IL-23 Signaling Cascade for New Therapeutic Opportunities. Cells 2020;9:E2044. [PMID: 32906785 DOI: 10.3390/cells9092044] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
7 Smejkal J, Malý P, Kuchař M, Panova N, Semerádtová A, Aubrecht P, Štofik M, Malý J. Cell immunocapture microfluidic chip based on high-affinity recombinant protein binders. Biosens Bioelectron 2021;172:112784. [PMID: 33161292 DOI: 10.1016/j.bios.2020.112784] [Reference Citation Analysis]
8 Aggarwal N, Breedon AME, Davis CM, Hwang IY, Chang MW. Engineering probiotics for therapeutic applications: recent examples and translational outlook. Current Opinion in Biotechnology 2020;65:171-9. [DOI: 10.1016/j.copbio.2020.02.016] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
9 Duarte SOD, Monteiro GA. Plasmid Replicons for the Production of Pharmaceutical-Grade pDNA, Proteins and Antigens by Lactococcus lactis Cell Factories. Int J Mol Sci 2021;22:1379. [PMID: 33573129 DOI: 10.3390/ijms22031379] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Zahirović A, Plavec TV, Berlec A. Dual Functionalized Lactococcus lactis Shows Tumor Antigen Targeting and Cytokine Binding in Vitro. Front Bioeng Biotechnol 2022;10:822823. [DOI: 10.3389/fbioe.2022.822823] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]